CLINICAL_TRIALS
trial_result
· 2013-02-05
Clinical Trial Update: Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures [Phase 3]
Summary
Phase 3 clinical trial update on Rufinamide as adjunctive therapy for refractory partial seizures in epilepsy patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-02-05